Review article · 2019 · Open access
Patient-reported outcome instruments in clinical trials of systemic sclerosis
Journal of Scleroderma and Related Disorders, 5(2), 90–102 · Published 25 November 2019 · DOI 10.1177/2397198319886496
In brief
“Patient-reported outcome instruments in clinical trials of systemic sclerosis” is a 2019 review article by John David Pauling and 6 co-authors, published in Journal of Scleroderma and Related Disorders. OpenAlex counts 32 citations as of 22 November 2026, which puts it in the top 8% of works published in 2019 by citations. It is open access: the full text is free to read at PubMed Central.
- Citations
- 32
- Most cited in
- 2022 (6)
- Field-weighted impact
- 0.50
- References
- 119
- Authors
- 7
Abstract
Patient-reported outcome instruments provide valuable insight into disease-related morbidity known only to the patient and complement more objective outcome tools in the clinical trial setting. They are of particular importance in systemic sclerosis owing to the challenges around defining disease activity, the episodic nature of many disease-specific manifestations and the paucity of validated objective surrogate outcome measures for use in clinical trials. Early clinical trials of systemic sclerosis often incorporated legacy patient-reported outcome instruments, but the last 20 years has witnessed the emergence of several scleroderma-specific instruments that are now being routinely used alongside other outcomes in systemic sclerosis clinical trials. More recently, the value of patient-reported outcomes has been highlighted by their prominence in the American College of Rheumatology Combined Response Index for Systemic Sclerosis that has been utilized as the primary endpoint of recent clinical trials of early diffuse systemic sclerosis. This review considers the role and performance of the various patient-reported outcome instruments utilized in systemic sclerosis clinical trials, the current positioning of patient-reported outcome instruments within clinical trial endpoint models across the range of systemic sclerosis disease manifestations and, where applicable, we shall highlight areas for future research.
Cite this paper
Formatted from the catalogue record. Check names, capitals and page numbers against the paper before you submit.
APA 7
Pauling, J. D., Caetano, J., Campochiaro, C., De Luca, G. D., Gheorghiu, A. M., Lazzaroni, M. G., & Khanna, D. (2019). Patient-reported outcome instruments in clinical trials of systemic sclerosis. Journal of Scleroderma and Related Disorders, 5(2), 90–102. https://doi.org/10.1177/2397198319886496
MLA 9
Pauling, John David, et al. “Patient-reported outcome instruments in clinical trials of systemic sclerosis.” Journal of Scleroderma and Related Disorders, vol. 5, no. 2, 2019, pp. 90–102. https://doi.org/10.1177/2397198319886496.
Chicago
Pauling, John David, Joana Caetano, Corrado Campochiaro, Giacomo Davide De Luca, Ana Maria Gheorghiu, Maria Grazia Lazzaroni, and Dinesh Khanna. 2019. “Patient-reported outcome instruments in clinical trials of systemic sclerosis.” Journal of Scleroderma and Related Disorders 5 (2): 90–102. https://doi.org/10.1177/2397198319886496.
Harvard
Pauling, J. D. et al. (2019) ‘Patient-reported outcome instruments in clinical trials of systemic sclerosis’, Journal of Scleroderma and Related Disorders, 5(2), pp. 90–102. doi:10.1177/2397198319886496.
IEEE
J. D. Pauling et al., “Patient-reported outcome instruments in clinical trials of systemic sclerosis,” Journal of Scleroderma and Related Disorders, vol. 5, no. 2, pp. 90–102, 2019, doi: 10.1177/2397198319886496.
BibTeX
@article{pauling2019patient,
title = {{Patient-reported outcome instruments in clinical trials of systemic sclerosis}},
author = {Pauling, John David and Caetano, Joana and Campochiaro, Corrado and De Luca, Giacomo Davide and Gheorghiu, Ana Maria and Lazzaroni, Maria Grazia and Khanna, Dinesh},
journal = {Journal of Scleroderma and Related Disorders},
year = {2019},
volume = {5},
number = {2},
pages = {90--102},
doi = {10.1177/2397198319886496},
url = {https://doi.org/10.1177/2397198319886496}
}
Download for a reference manager: BibTeX (.bib) · RIS for Zotero, Mendeley and EndNote (.ris)
Citations by year
| Year | Citations | Share of the best year |
|---|---|---|
| 2020 | 4 | |
| 2021 | 4 | |
| 2022 | 6 | |
| 2023 | 2 | |
| 2024 | 5 | |
| 2025 | 6 | |
| 2026 | 5 |
Its field-weighted citation impact is 0.50: it has been cited 0.50 times as often as the average work of the same field, type and year (1.00 is the world average).
Topic and keywords
Health Sciences › Medicine › Rheumatology › Systemic Sclerosis and Related Diseases
- systemic sclerosis
- patient-reported outcome measures
- clinical trial endpoints
- disease activity
- disease manifestations
Work with this paper
Most-cited papers in Medicine
- Yaşlı Kadınlarda Üreme SağlığıDemet Kokanalı, Yaprak Engin Üstün · Jinekoloji-Obstetrik ve Neonatoloji Tıp Dergisi · 2019 · 169,630 citations
- Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 CountriesHyuna Sung, Adalberto M. Filho, Mathieu Laversanne and 5 more · CA A Cancer Journal for Clinicians · 2021 · 119,885 citations
- “Mini-mental state”Marshal F. Folstein, Susan E. Folstein, Paul R. McHugh · Journal of Psychiatric Research · 1975 · 90,424 citations
- Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countriesFreddie Bray, Jacques Ferlay, Isabelle Soerjomataram and 3 more · CA A Cancer Journal for Clinicians · 2018 · 87,396 citations
- Hallmarks of Cancer: The Next GenerationDouglas Hanahan, Robert A. Weinberg · Cell · 2011 · 69,758 citations
Questions about this paper
How do I cite this paper in APA style?
Pauling, J. D., Caetano, J., Campochiaro, C., De Luca, G. D., Gheorghiu, A. M., Lazzaroni, M. G., & Khanna, D. (2019). Patient-reported outcome instruments in clinical trials of systemic sclerosis. Journal of Scleroderma and Related Disorders, 5(2), 90–102. https://doi.org/10.1177/2397198319886496
How many times has this paper been cited?
32 times, according to OpenAlex on 22 November 2026. Google Scholar and Scopus count different sets of sources, so their numbers differ.
Is this paper free to read?
Yes. It is open access at PubMed Central: sign in and open the full text from this page.
Who wrote this paper?
John David Pauling, Joana Caetano, Corrado Campochiaro, Giacomo Davide De Luca, Ana Maria Gheorghiu, Maria Grazia Lazzaroni, Dinesh Khanna.
What is the DOI of this paper?
10.1177/2397198319886496, permanently at https://doi.org/10.1177/2397198319886496. Sign in and open it from this page.
Bibliographic data from OpenAlex (CC0), last checked 22 November 2026. ResearchGuru does not host this paper; once you are signed in, the links open it at the publisher or the repository that does.